Cargando…

Scotoma analysis of 10-2 visual field testing with a white target in screening for hydroxychloroquine retinopathy

OBJECTIVE: To quantify the variability of scotomas detected by 10-2 visual field (VF) testing in patients taking hydroxychloroquine without and with retinopathy. DESIGN: Retrospective review of clinical charts and visual fields. SUBJECTS: Twenty-one patients taking hydroxychloroquine without retinop...

Descripción completa

Detalles Bibliográficos
Autores principales: Browning, David J, Lee, Chong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4454213/
https://www.ncbi.nlm.nih.gov/pubmed/26060390
http://dx.doi.org/10.2147/OPTH.S82398
_version_ 1782374578117410816
author Browning, David J
Lee, Chong
author_facet Browning, David J
Lee, Chong
author_sort Browning, David J
collection PubMed
description OBJECTIVE: To quantify the variability of scotomas detected by 10-2 visual field (VF) testing in patients taking hydroxychloroquine without and with retinopathy. DESIGN: Retrospective review of clinical charts and visual fields. SUBJECTS: Twenty-one patients taking hydroxychloroquine without retinopathy, and nine patients taking hydroxychloroquine and one patient taking chloroquine with retinopathy. METHODS: Retinopathy was defined by annular scotomas on 10-2 VF testing with corroborative spectral domain optical coherence tomographic outer retinal changes and multifocal electroretinographic changes leading to cessation of hydroxychloroquine or chloroquine. Location and depth of scotoma points on 10-2 VF testing were recorded and their fates followed in serial, reliable 10-2 VFs performed with a white target over time. MAIN OUTCOME MEASURES: Number of scotoma points and locations, percentage of persistent scotoma points, size of scotomas, location of scotomas, and percentage of scotomas deepening. RESULTS: A median of five, interquartile range (IQR) 3–8 scotoma points per VF occurred in patients without retinopathy. A median of 86%, IQR 63%–100% of these points resolve on the subsequent field. For patients with retinopathy, a median of 22%, IQR 10%–59% resolve. The median percentage of scotoma points in the zone 2–8 degrees from fixation in eyes with retinopathy was 79%, IQR 68%–85% compared to 60%, IQR 54%–75% in eyes without retinopathy (P=0.0094). Single-point scotomas were more common in eyes without than with retinopathy. Scotomas consisting of more than four contiguous scotoma points were generally indicative of retinopathy. CONCLUSION: Point scotomas are common and variable in 10-2 VF testing with a white target for hydroxychloroquine retinopathy in subjects without retinopathy. The annular zone 2 to 8 degrees from fixation was useful for distinguishing the significance of scotoma points. Scotomas with more contiguous scotoma points were more often associated with retinopathy.
format Online
Article
Text
id pubmed-4454213
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-44542132015-06-09 Scotoma analysis of 10-2 visual field testing with a white target in screening for hydroxychloroquine retinopathy Browning, David J Lee, Chong Clin Ophthalmol Original Research OBJECTIVE: To quantify the variability of scotomas detected by 10-2 visual field (VF) testing in patients taking hydroxychloroquine without and with retinopathy. DESIGN: Retrospective review of clinical charts and visual fields. SUBJECTS: Twenty-one patients taking hydroxychloroquine without retinopathy, and nine patients taking hydroxychloroquine and one patient taking chloroquine with retinopathy. METHODS: Retinopathy was defined by annular scotomas on 10-2 VF testing with corroborative spectral domain optical coherence tomographic outer retinal changes and multifocal electroretinographic changes leading to cessation of hydroxychloroquine or chloroquine. Location and depth of scotoma points on 10-2 VF testing were recorded and their fates followed in serial, reliable 10-2 VFs performed with a white target over time. MAIN OUTCOME MEASURES: Number of scotoma points and locations, percentage of persistent scotoma points, size of scotomas, location of scotomas, and percentage of scotomas deepening. RESULTS: A median of five, interquartile range (IQR) 3–8 scotoma points per VF occurred in patients without retinopathy. A median of 86%, IQR 63%–100% of these points resolve on the subsequent field. For patients with retinopathy, a median of 22%, IQR 10%–59% resolve. The median percentage of scotoma points in the zone 2–8 degrees from fixation in eyes with retinopathy was 79%, IQR 68%–85% compared to 60%, IQR 54%–75% in eyes without retinopathy (P=0.0094). Single-point scotomas were more common in eyes without than with retinopathy. Scotomas consisting of more than four contiguous scotoma points were generally indicative of retinopathy. CONCLUSION: Point scotomas are common and variable in 10-2 VF testing with a white target for hydroxychloroquine retinopathy in subjects without retinopathy. The annular zone 2 to 8 degrees from fixation was useful for distinguishing the significance of scotoma points. Scotomas with more contiguous scotoma points were more often associated with retinopathy. Dove Medical Press 2015-05-27 /pmc/articles/PMC4454213/ /pubmed/26060390 http://dx.doi.org/10.2147/OPTH.S82398 Text en © 2015 Browning and Lee. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Browning, David J
Lee, Chong
Scotoma analysis of 10-2 visual field testing with a white target in screening for hydroxychloroquine retinopathy
title Scotoma analysis of 10-2 visual field testing with a white target in screening for hydroxychloroquine retinopathy
title_full Scotoma analysis of 10-2 visual field testing with a white target in screening for hydroxychloroquine retinopathy
title_fullStr Scotoma analysis of 10-2 visual field testing with a white target in screening for hydroxychloroquine retinopathy
title_full_unstemmed Scotoma analysis of 10-2 visual field testing with a white target in screening for hydroxychloroquine retinopathy
title_short Scotoma analysis of 10-2 visual field testing with a white target in screening for hydroxychloroquine retinopathy
title_sort scotoma analysis of 10-2 visual field testing with a white target in screening for hydroxychloroquine retinopathy
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4454213/
https://www.ncbi.nlm.nih.gov/pubmed/26060390
http://dx.doi.org/10.2147/OPTH.S82398
work_keys_str_mv AT browningdavidj scotomaanalysisof102visualfieldtestingwithawhitetargetinscreeningforhydroxychloroquineretinopathy
AT leechong scotomaanalysisof102visualfieldtestingwithawhitetargetinscreeningforhydroxychloroquineretinopathy